AGIO

#1742
Agios Pharmaceuticals, Inc. - Common Stock
29.4 0 USD
-3.35%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
29.38
29.40
Range Annuel
0.28
45.99
Changement quotidien
-3.35%
Changement Mensuel
+4.74%
Evolution sur 6 mois
+3.12%
Changement Annuel
-32.24%
Clôture Précédente
30.4 2
Open
29.3 8
Low
29.3 8
High
29.4 0
Volume
121
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 1.75 B
  • Employee 540
  • Founded 2008
  • CEO N/A
  • Website www.agios.com
  • Headquarter Delaware, United States
  • FIGI BBG000QY4ZD0
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-3.82
ratio cours/chiffre d'affaires
29.21

Agios Pharmaceuticals, Inc. - Common Stock

Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.

Nouvelles